A Single-Center, Double-Blind, Randomized, Split-Face, Controlled Clinical Trial to Evaluate and Compare the Efficacy and Tolerance of a Thiamidol-containing Product and Hydroquinone-containing Product When Used by Women with Mild to Moderate Melasma